On Target Laboratories, LLC
On Target Laboratories is dedicated to developing targeted intraoperative molecular imaging agents to illuminate cancer during surgery, aiming to help surgeons detect and remove more cancerous tissue for better patient outcomes. Their mission is to illuminate cancer intraoperatively so it can be removed completely, driven by core values of innovation, compassion, optimism, integrity, focus, and agility.
Industries
Nr. of Employees
medium (51-250)
On Target Laboratories, LLC
Patents
Synthesis and composition of photodynamic therapeutic agents for the targeted treatment of cancer
US-12144874-B2
View DetailsCompositions including pafolacianine for the identification of malignant lesions
US-11986540-B2
View DetailsMethods of manufacture and synthesis of fluorescent dye compounds and uses thereof
US-11964965-B2
View Details
Synthesis and composition of photodynamic therapeutic agents for the targeted treatment of cancer
US-12144874-B2
View DetailsCompositions including pafolacianine for the identification of malignant lesions
US-11986540-B2
View DetailsMethods of manufacture and synthesis of fluorescent dye compounds and uses thereof
US-11964965-B2
View DetailsProducts
Folate receptor–targeted near-infrared optical imaging agent for intraoperative identification of ovarian and pulmonary lesions
An intravenously administered small-molecule ligand–dye conjugate that targets folate receptors on cancer cells and produces near-infrared fluorescence to assist surgeons in identifying malignant and non-malignant pulmonary lesions and malignant ovarian lesions during surgery.
Folate receptor–targeted near-infrared optical imaging agent for intraoperative identification of ovarian and pulmonary lesions
An intravenously administered small-molecule ligand–dye conjugate that targets folate receptors on cancer cells and produces near-infrared fluorescence to assist surgeons in identifying malignant and non-malignant pulmonary lesions and malignant ovarian lesions during surgery.
Services
Program to provide investigational imaging agents outside clinical trials for qualifying patients, including coordination of submissions under an open IND and site/investigator training to administer the agent with required NIR camera systems.
Sponsor-side clinical development services including protocol development, site selection, GCP oversight, CRO management, monitoring, CRF/IVRS support and publication of clinical results.
Program to provide investigational imaging agents outside clinical trials for qualifying patients, including coordination of submissions under an open IND and site/investigator training to administer the agent with required NIR camera systems.
Sponsor-side clinical development services including protocol development, site selection, GCP oversight, CRO management, monitoring, CRF/IVRS support and publication of clinical results.
Expertise Areas
- Intraoperative molecular imaging
- Small-molecule targeted imaging agent development
- Clinical trial design and execution (Phase I–III)
- Regulatory strategy and submissions (IND/NDA)
Key Technologies
- Near-infrared fluorescence imaging
- Small-molecule ligand–dye conjugates
- Folate receptor–targeted biomarker targeting
- Intravenous infusion administration for imaging agents
News & Updates
CYTALUX® was recognized as the Most Innovative Product of the Year in Healthcare and Medical category by the 2024 Best in Biz Awards.
CYTALUX® was recognized as the Most Innovative Product of the Year in Healthcare and Medical category by the 2024 Best in Biz Awards.